BioNTech (BNTX) free cash flow

Free cash flow · fiscal 2025
-€293.00M

BioNTech (BNTX) generated free cash flow of -€293.00M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -€244.60M. Figures as of 18 Nov 2026, 12:22 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-€293.00M
Highest on record
€13.21Bfiscal 2022
Lowest on record
-€293.00Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

BioNTech free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €13.21B in fiscal 2022 and the lowest -€293.00M in fiscal 2025.

History · 4 fiscal years

Free cash flow by fiscal year

BioNTech free cash flow, year by year

BioNTech (BNTX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-€293.00M—
2024-€244.60M 105.2% down
2023€4.67B 64.7% down
2022€13.21B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of BioNTech and comparable companies
CompanyFree cash flowFiscal year
Viatris VTRS$1.85B2025
Tenet Healthcare THC$2.53B2025
BioNTech BNTX-€293.00M2025
Guardant Health GH-$233.07M2025
Alnylam Pharmaceuticals ALNY$465.38M2025
Zimmer Biomet Holdings ZBH$1.42B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BNTX

BioNTech, figure by figure

BioNTech (BNTX) overview: price, valuation and scorecardAll health care companies by market value

BioNTech free cash flow: questions and answers

What is BioNTech's free cash flow?

BioNTech (BNTX) generated free cash flow of -€293.00M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -€244.60M.

What are the highest and lowest free cash flow figures on record for BioNTech?

Across the 4 fiscal years on record (2022–2025), the highest was €13.21B in fiscal 2022 and the lowest -€293.00M in fiscal 2025.

How is BioNTech's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For BioNTech it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioNTech (BNTX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/BNTX/free-cash-flow

Underlying data: Yahoo Finance.